TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-1.94 Cr | ₹-0.15 Cr | ₹-0.52 Cr | ₹-1.04 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TRIDENT LIFELINE ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-1.94 Cr |
| Mar2024 | ₹-0.15 Cr |
| Mar2023 | ₹-0.52 Cr |
| Mar2022 | ₹-1.04 Cr |
How is Deferred Tax Assets / Liabilities of TRIDENT LIFELINE Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.94 Cr | Negative | |
| Mar2024 | ₹-0.15 Cr | Negative | |
| Mar2023 | ₹-0.52 Cr | Negative | |
| Mar2022 | ₹-1.04 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹297.6 Cr | -1% | -3.4% | 1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,848.0 Cr | 11.6% | 0.7% | -0.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,697.0 Cr | 2.3% | 8.5% | 8.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,859.0 Cr | 1.8% | -1.8% | 30.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,421.0 Cr | 0.5% | 3.2% | 13.3% | Stock Analytics | |
| CIPLA | ₹105,811.0 Cr | 1.2% | 5.4% | -13.7% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -1% |
-3.4% |
1.4% |
| SENSEX | -1% |
2.2% |
-3.6% |
You may also like the below Video Courses